Ved skift af patienter fra oral opløsning til tabletformulering anbefales det at give samme dosis og verificere laveste sirolimus koncentration 1 til 2 uger efter, for at sikre at koncentrationen er inden for de anbefalede målområder.
When switching patients between oral solution and tablet formulations, it is recommended to give the same dose and to verify the sirolimus trough concentration 1 to 2 weeks later to assure that it remains within recommended target ranges.